RJ Tesi, M.D., co-founder and CEO of clinical-stage
immunology company INmune Bio (NASDAQ: INMB), was recently featured in an
interview with multimedia financial reporter Jason Lin. Among other highlights,
Dr. Tesi discusses recent company accomplishments in the interview. “Nasdaq’s
MarketSite is a premiere platform for INmune Bio to share our story with
investors and to discuss recent developments in our programs for cancer,
Alzheimer’s disease and nonalcoholic steatohepatitis (NASH) liver disease,”
INmune co-founder and CEO Dr. RJ Tesi stated in the interview. “We hope to
continue reaching new milestones in the development of therapies that target
the innate immune system.” The company also announced today that CJ Barnum,
Ph.D., Director of Neuroscience, will be presenting on “Approaching Alzheimer’s
disease as an immunological disease: role of biomarkers” at the World
Immunotherapy Congress taking place on October 16 in Switzerland.
To view the interview, visit http://ibn.fm/298yz
To view the full press release, visit http://ibn.fm/ypk9K
About INmune Bio, Inc.
INmune Bio is a publicly traded, clinical-stage
biotechnology company focused on developing treatments that target the innate
immune system to fight disease. INmune Bio has two product platforms. The
DN-TNF product platform utilizes dominant-negative technology to selectively
neutralize soluble TNF, a key driver of innate immune dysfunction and
mechanistic target of many diseases. DN-TNF is currently being developed for
cancer (INB03), Alzheimer’s (XPro595), and NASH (NeuLiv). The Innate Immune
Priming Platform includes INKmune aimed at priming the patient’s NK cells to
eliminate minimal residual disease in patients with cancer. INmune Bio’s
product platforms utilize a precision medicine approach for the treatment of a wide
variety of hematologic malignancies, solid tumors and chronic inflammation. For
more information, visit the company’s website at www.INmuneBio.com.
NOTE TO INVESTORS: The latest news and updates
relating to INMB are available in the company’s newsroom at http://ibn.fm/INMB
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment